Global Microfluidics Market Size, Share and Forecast 2029F

Summary

Report Description

Forecast Period	2025-2029
Market Size (2023)	USD 24.48 Billion
Market Size (2029)	USD 83.22 Billion
CAGR (2024-2029)	22.70%
Fastest Growing Segment	Polymer
Largest Market	North America

Market Overview

Global Microfluidics Market has valued at USD 24.48 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 22.70% through 2029. Microfluidics, a branch of technology, utilizes minuscule channels to precisely control and manipulate fluids, ranging from microliters to picoliters in quantity. It has emerged as a distinct field of study, finding applications in various academic disciplines such as chemistry, biology, medicine, and the physical sciences. This highly effective technology enables rapid analysis, accurate test results, and cost reduction in drug innovation methods, making it applicable across multiple healthcare contexts. The advancement of lab-on-chip (LOC) technologies, poised to revolutionize chemistry and biology akin to integrated circuits in computing, serves as the driving force behind microfluidic research. By incorporating microfluidic channels and active or passive components like valves, filters, and mixers, LOCs function as microsystems capable of integrating complete biological or chemical laboratories onto a single chip.

Key Market Drivers

Increasing Demand for Point-of-care Testing

The increasing demand for point-of-care testing (POCT) is driving the growth of microfluidics technology. Microfluidics is a field that deals with the manipulation of small amounts of fluids, typically at the microliter or nanoliter scale, within microscale channels or devices. Point-of-care testing involves conducting diagnostic tests near the patient, rather than sending samples to a central laboratory. Microfluidic devices are well-suited for POCT because they enable rapid and efficient testing, which is crucial for timely medical decisions. Microfluidic devices require smaller sample volumes compared to traditional laboratory testing methods. This is advantageous for point-of-care settings where obtaining large blood or tissue samples can be challenging or uncomfortable for patients.

Microfluidic devices are often compact and portable, making them suitable for use in various healthcare settings, including clinics, ambulances, remote areas, and even in-home healthcare. The portability of microfluidic systems aligns with the requirements of POCT. POCT aims to provide rapid results to facilitate immediate clinical decisions. Microfluidic devices can deliver quick test results, allowing healthcare providers to make timely treatment recommendations. Microfluidics technology can be adapted to perform a wide range of tests, including blood tests, genetic testing, infectious disease diagnostics, and more. The versatility of microfluidic platforms makes them applicable for a variety of point-of-care scenarios. Microfluidic systems can achieve high levels of accuracy and sensitivity in diagnostic tests. This is critical for POCT applications where precise measurements are essential for diagnosing and monitoring diseases.

Increasing Incidences of Chronic Diseases

Microfluidic devices can be used for the early detection of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Early detection is crucial for better treatment outcomes and improved patient survival rates. Microfluidics technology plays a key role in advancing precision medicine. It allows for the analysis of individual patient samples at a molecular level, aiding in the development of tailored treatment plans and targeted therapies for chronic diseases. Microfluidic devices are inherently miniaturized and can perform a wide range of diagnostic tests with small sample volumes. This is particularly advantageous for patients with chronic diseases, as it reduces discomfort associated with sample collection.

Many chronic diseases require continuous monitoring of biomarkers and physiological parameters. Microfluidic systems can enable real-time monitoring, helping healthcare providers detect changes in a patient's condition and adjust treatment plans accordingly. Microfluidics is valuable in drug development and high-throughput screening for chronic disease treatments. It allows for the testing of multiple drug compounds and their effects on disease-related biomarkers, expediting drug discovery processes. Microfluidics facilitates the analysis of various biological fluids, including blood, urine, and saliva. This enables the monitoring of disease markers and physiological changes associated with chronic conditions. Early detection and continuous monitoring through microfluidic technology can help manage chronic diseases more efficiently. By preventing disease progression and complications, it can ultimately reduce the long-term healthcare costs associated with chronic conditions.

Faster Turn-around Time for Analysis and Improved Portability of Devices

Microfluidic devices enable the rapid analysis of samples, reducing the time required for diagnostic tests. This is particularly important in healthcare, where quick results can lead to more timely treatment decisions and improved patient outcomes. Microfluidics technology requires smaller sample volumes than traditional laboratory methods. This is especially valuable when dealing with limited or precious samples, such as those obtained from pediatric patients or in research settings. Despite their small size, microfluidic devices can process multiple samples simultaneously. This high-throughput capability is beneficial in clinical laboratories where large numbers of samples need to be analyzed quickly.

Microfluidic devices are often compact and portable, making them suitable for use in various settings, including remote areas, ambulances, field research, and even at-home healthcare. Their portability enhances access to diagnostics and monitoring. Faster analysis reduces the strain on healthcare resources and personnel. Microfluidic devices require less time and labor to produce results, allowing healthcare providers to allocate their resources more efficiently. Rapid diagnostic tests align with the principles of patient-centered care, where patients are actively involved in their healthcare decisions. Patients appreciate receiving quick results and immediate feedback on their health status. Faster diagnostic results enable the early detection of diseases and conditions, which is often crucial for effective treatment and improved patient outcomes.

Increased the Demand for Microfluidics Tools

Researchers across various fields, including biology, chemistry, and physics, are increasingly utilizing microfluidics tools for experimentation and analysis. As the demand for cutting-edge research grows, so does the demand for the tools that enable it. Microfluidics tools can significantly enhance laboratory efficiency. They enable the precise manipulation of tiny volumes of liquids, leading to reduced sample wastage and faster experiments. As laboratories seek to streamline their processes and reduce costs, the adoption of microfluidics tools becomes more attractive.

Microfluidics tools can be customized for specific research needs. Researchers can design and fabricate microfluidic devices tailored to their experiments, providing a level of flexibility and control that traditional methods often lack. Microfluidics has found applications in diverse fields, such as genomics, proteomics, drug discovery, and diagnostics. As new applications continue to emerge, the demand for specialized microfluidics tools grows in tandem. Microfluidics tools are vital in biomedical research, enabling the study of cell behavior, tissue engineering, drug screening, and diagnostics. The growing focus on understanding complex biological systems drives the demand for these tools. Pharmaceutical companies use microfluidics tools for drug formulation, high-throughput screening, and pharmacokinetic studies. As drug development pipelines expand, so does the need for efficient tools to accelerate the process.

Download Free Sample Report

Key Market Challenges

Scaling for Mass Production

Transitioning from prototype or research-level microfluidic devices to mass production is a complex process that presents numerous challenges. While research and development efforts often focus on proving the concept and demonstrating functionality, scaling up production requires a different set of considerations. Research-level microfluidic devices are typically fabricated using manual or low-throughput methods that are unsuitable for mass production. Transitioning to large-scale manufacturing demands the development of automated, high-throughput fabrication processes capable of producing thousands or millions of devices consistently. The choice of materials for research prototypes may differ from those suitable for mass production. Compatibility with scalable manufacturing processes, cost-effectiveness, and the ability to meet regulatory requirements are essential considerations. Achieving uniform performance across all devices in mass production can be difficult. Variations in manufacturing processes, materials, and environmental factors must be tightly controlled to ensure consistent device performance.

Regulatory Challenges

Microfluidic devices used in clinical applications or diagnostics may need to adhere to regulatory standards and undergo validation processes. Navigating the regulatory landscape can be time-consuming and costly. Before clinical trials, microfluidic devices undergo extensive preclinical testing to assess their performance, accuracy, and reliability. This phase involves in-depth laboratory testing and validation, which can be time-consuming and costly. Microfluidic devices used in clinical applications and diagnostics play a pivotal role in modern healthcare, offering the promise of faster, more accurate, and more personalized diagnostics and treatments. However, their journey from innovation to widespread clinical adoption is often hampered by rigorous regulatory standards and validation processes.

To ensure patient safety and the reliability of diagnostic results, microfluidic devices must comply with stringent regulatory requirements established by health authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations demand comprehensive documentation, quality control measures, and validation studies to prove the safety and efficacy of these devices. Developers must establish robust quality management systems to ensure consistent manufacturing and adherence to regulatory standards. This includes good manufacturing practices (GMP) and quality control measures.

Key Market Trends

Development of New Products

New microfluidic products often bring novel capabilities and functionalities. These innovations open up opportunities for applications in various industries, from healthcare and biotechnology to environmental monitoring and beyond. New products often offer improved performance characteristics, such as increased precision, sensitivity, and reliability. This makes microfluidics more attractive for researchers and industries that require high-quality results. User-friendly features and improved automation in new microfluidic devices can reduce the learning curve for end-users. This encourages wider adoption across different skill levels and applications.

In March 2021, the Loschmidt laboratories team collaborated with ETH Zurich partners to establish a microfluidic platform for efficient and rapid investigation of enzymes and their properties. The innovative platform has already been utilized in the development of new thrombolytics for stroke treatment and the study of the evolutionary aspects of bioluminescent enzymes. Additionally, in November 2019, Panasonic Corporation and IMT joined forces to pioneer a technology for mass production of microfluidic devices using glass moulding. This cost-effective and highly accurate production technique surpasses traditional glass etching methods. These devices find extensive applications in biological, environmental, and medical analysis and sensing, making them a key driver in the microfluidics market during the forecast period.

Growing Demand of Personalized Medicine

The growing demand for personalized medicine is expected to significantly boost the demand for microfluidics technology. Personalized medicine aims to tailor medical treatments to the unique characteristics of each patient, including their genetic makeup, biomarker profiles, and lifestyle factors. Microfluidics technology enables the rapid and cost-effective analysis of small sample volumes, making it ideal for obtaining the precise data required for personalized treatment plans. Microfluidics plays a crucial role in genomics and proteomics research, where the analysis of DNA, RNA, proteins, and other molecules is essential for understanding disease mechanisms and predicting treatment responses. Microfluidic platforms can efficiently sequence genes, perform gene expression analysis, and characterize proteins, facilitating the identification of molecular targets for personalized therapies.

Pharmacogenomics involves studying how an individual's genetic variations influence their response to medications. Microfluidic devices can be used to assess genetic variants associated with drug metabolism, allowing healthcare providers to select the most effective and safest treatments for each patient. Microfluidics accelerates biomarker discovery, helping identify specific biomarkers associated with diseases or treatment responses. These biomarkers are essential for patient stratification and the development of targeted therapies.

Segmental Insights

Material Insights

Based on the material, the market is segmented into silicon, glass, polymer, PDMS, and others. The polydimethylsiloxane (PDMS) segment is expected to be the highest growing segment in the microfluidics market in 2023 and is expected to experience growth throughout the forecast period. PDMS, a widely used polymer in microfluidics, offers several advantages. These include nontoxicity, robustness, optical transparency, gas and oxygen permeability, biocompatibility, elastomeric properties, cost-effectiveness, and the ability to create complex designs by stacking multiple layers in microfluidic devices. The rapid adoption of microfluidics-enabled lab-on-a-chip (LOC) devices has opened up numerous growth opportunities for PDMS utilization in experimental microfluidics. Due to its biocompatibility, permeability, and low autofluorescence levels, PDMS is projected to gain significant traction in various biotechnology and biomedical engineering applications during the forecast period. However, it is important to note that these polymers are hydrophobic, which can pose challenges in operating microchannels in aqueous solutions. Hydrophobic analytes tend to adsorb onto the surface of PDMS, impeding analysis. These factors may limit the widespread adoption of PDMS materials.

Application Insights

Based on the application segment, the lab-on-a-chip segment emerged as the dominant force in the field of microfluidics in 2023 and is expected to maintain its dominance throughout the forecast period. Leveraging its capabilities, the lab-on-chip enables rapid DNA probe sequencing by facilitating high-speed thermal shifts at the microscale level, crucial for DNA amplification through the PCR technique. Elveflow, a leading provider, offers the Fastgene system, a state-of-the-art qPCR system that can detect bacteria and viruses within a remarkable 7-minute timeframe. Furthermore, nanopore technologies exhibit immense potential in expediting genome sequencing of DNA probes compared to conventional lab-on-a-chip approaches using array techniques. This technology also presents lucrative opportunities for ultra-fast immunoassays, reducing the time needed from 10 minutes to a mere 10 seconds when compared to macroscopic technologies. Hence, the utilization of lab-on-a-chip systems holds immense promise in rapid virus and bacteria detection. Conversely, recent advancements in lab-on-a-chip research have demonstrated its potential in the field of cell biology. These systems showcase the ability to regulate individual cells while effectively managing a large volume of cells within a short time frame. Elveflow's Opto Reader, a fast-optical detector, facilitates the detection and isolation of cells, making notable contributions to stem cell differentiation, micro patch-clamp techniques, cell sorting, and high-speed flow cytometry.

Download Free Sample Report

Regional Insights

North America emerged as the dominant force in the regional microfluidics market in 2023 and is poised for growth throughout the forecast period. The market's expansion is primarily fueled by increased research funding from government organizations and industries. The demand for microfluidics devices in the research and diagnostics field has prompted collaboration between industry and academia to expedite the commercialization of laboratory-built devices. Meanwhile, Asia Pacific is anticipated to experience significant growth at a rate of 16.08% during the forecast period, owing to its advanced research infrastructure, developing economy, and cost-effective labor. International players are showing a keen interest in investing in the untapped microfluidics market in the APAC region. Although foreign players currently dominate the market for diagnostic tests based on microfluidics, key players in the region are proposing innovative and competitive solutions in terms of performance, and most notably, price, which positions them to enhance their market share in the years to come.

Recent Developments

In September 2023, CellFE Inc., a life sciences tools company focused on advancing cell therapies through its microfluidics-based cell engineering platform, www.cellfebiotech.com, announced the successful closure of a $22 million Series A financing round. The financing was spearheaded by M Ventures, with additional contributions from Great Point Ventures and Riverine Ventures, along with existing investors including Cota Capital, Dynamk Capital, Elm Street Ventures, Embark Ventures, EGB Capital, and Khosla Ventures.

Key Market Players

UFluidix
Bio-Rad Laboratories Inc.
Emulate Inc.
Dolomite Microfluidics (Blacktrace Holdings Ltd)
Sphere Fluidics Limited
FluIdigm Corporation
Illumina Inc.
Micronit Microfluidics
PerkinElmer Inc.
Hesperos Inc.

By Technology	By Material	By Application	By Region
Medical/Healthcare Non-medical	Silicon Glass Polymer PDMS Others	Lab-on-a-chip Organs-on-chips Continuous flow microfluidics Optofluidics and microfluidics Acoustofluidics and microfluidics Electrophoresis and microfluidics	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Microfluidics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidics Market, By Technology:

o Medical/Healthcare

o Non-medical

Microfluidics Market, By Material:

o Silicon

o Glass

o Polymer

o PDMS

o Others

Microfluidics Market, By Application:

o Lab-on-a-chip

o Organs-on-chips

o Continuous flow microfluidics

o Optofluidics and microfluidics

o Acoustofluidics and microfluidics

o Electrophoresis and microfluidics

Microfluidics Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia-Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microfluidics Market.

Available Customizations:

Global Microfluidics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Microfluidics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validations

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microfluidics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Technology (Medical/Healthcare, Non-medical)

5.2.2. By Material (Silicon, Glass, Polymer, PDMS, Others)

5.2.3. By Application (Lab-on-a-chip, Organs-on-chips, Continuous flow microfluidics, Optofluidics and microfluidics, Acoustofluidics and microfluidics, Electrophoresis and microfluidics)

5.2.4. By Region

5.2.5. By Company (2023)

5.3. Market Map

6. North America Microfluidics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Technology

6.2.2. By Material

6.2.3. By Application

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Microfluidics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Technology

6.3.1.2.2. By Material

6.3.1.2.3. By Application

6.3.2. Canada Microfluidics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Technology

6.3.2.2.2. By Material

6.3.2.2.3. By Application

6.3.3. Mexico Microfluidics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Technology

6.3.3.2.2. By Material

6.3.3.2.3. By Application

7. Europe Microfluidics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Technology

7.2.2. By Material

7.2.3. By Application

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Microfluidics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Technology

7.3.1.2.2. By Material

7.3.1.2.3. By Application

7.3.2. United Kingdom Microfluidics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Technology

7.3.2.2.2. By Material

7.3.2.2.3. By Application

7.3.3. Italy Microfluidics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Technology

7.3.3.2.2. By Material

7.3.3.2.3. By Application

7.3.4. France Microfluidics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Technology

7.3.4.2.2. By Material

7.3.4.2.3. By Application

7.3.5. Spain Microfluidics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Technology

7.3.5.2.2. By Material

7.3.5.2.3. By Application

8. Asia-Pacific Microfluidics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Technology

8.2.2. By Material

8.2.3. By Application

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Microfluidics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Technology

8.3.1.2.2. By Material

8.3.1.2.3. By Application

8.3.2. India Microfluidics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Technology

8.3.2.2.2. By Material

8.3.2.2.3. By Application

8.3.3. Japan Microfluidics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Technology

8.3.3.2.2. By Material

8.3.3.2.3. By Application

8.3.4. South Korea Microfluidics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Technology

8.3.4.2.2. By Material

8.3.4.2.3. By Application

8.3.5. Australia Microfluidics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Technology

8.3.5.2.2. By Material

8.3.5.2.3. By Application

9. South America Microfluidics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Technology

9.2.2. By Material

9.2.3. By Application

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Microfluidics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Technology

9.3.1.2.2. By Material

9.3.1.2.3. By Application

9.3.2. Argentina Microfluidics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Technology

9.3.2.2.2. By Material

9.3.2.2.3. By Application

9.3.3. Colombia Microfluidics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Technology

9.3.3.2.2. By Material

9.3.3.2.3. By Application

10. Middle East and Africa Microfluidics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Technology

10.2.2. By Material

10.2.3. By Application

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Microfluidics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Technology

10.3.1.2.2. By Material

10.3.1.2.3. By Application

10.3.2. Saudi Arabia Microfluidics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Technology

10.3.2.2.2. By Material

10.3.2.2.3. By Application

10.3.3. UAE Microfluidics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Technology

10.3.3.2.2. By Material

10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Microfluidics Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. UFluidix

15.1.1. Business Overview

15.1.2. Company Snapshot

15.1.3. Products & Services

15.1.4. Financials (As Reported)

15.1.5. Recent Developments

15.1.6. Key Personnel Details

15.1.7. SWOT Analysis

15.2. Bio-Rad Laboratories Inc.

15.3. Emulate Inc.

15.4. Dolomite Microfluidics (Blacktrace Holdings Ltd)

15.5. Sphere Fluidics Limited

15.6. FluIdigm Corporation

15.7. Illumina Inc.

15.8. Micronit Microfluidics

15.9. PerkinElmer Inc.

15.10. Hesperos Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions

What was the market size of the Global Microfluidics Market in 2023?

The market size of the Global Microfluidics Market was estimated to be USD 24.48 Billion in 2023.

Which was the dominant segment by application in the Global Microfluidics Market in 2023?

The lab-on-a-chip application accounted for the largest revenue share in the global microfluidics market in 2023 and is projected to maintain its position throughout the analysis period.

Which is the dominant region in the Global Microfluidics Market?

North America has emerged as the largest stakeholder in the global microfluidics market. This can be attributed to the presence of well-established market players in the region, the introduction of advanced technologies, an increase in the number of studies aimed at improving sample optimization, and a significant demand for POC diagnostics.

What are the major drivers for the Global Microfluidics Market?

Increase in demand for point-of-care (POC) devices and development of advanced lab-on-a-chip technologies are the major drivers for the Global Microfluidics Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Microfluidics Market to Grow with a CAGR of 22.70% through 2029

Mar, 2024

Rising demand for point-of-care testing and increasing number of the elderly population & the spread of chronic diseases worldwide is expected to drive the Global Microfluidics Market growth in the f

Buy Now